Phase Ib study of sintilimab in combination with chemotherapy for 1L advanced or metastatic nonsmall cell lung cancer (NSCLC)

Category Primary study
JournalJournal of Clinical Oncology
Year 2019
This article has no abstract
Epistemonikos ID: eac69002112e563f49e56808a072c6a01231f51f
First added on: Feb 11, 2025